{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/01/3304100/31990/en/Agios-Enters-Exclusive-Global-License-Agreement-with-Oscotec-to-Develop-and-Commercialize-Next-Generation-SYK-Inhibitor-Cevidoplenib.html", "message": "News view counter 769389 successfully enlarged"}